{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:23:05Z","timestamp":1771539785430,"version":"3.50.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.cll.2017.05.009","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:18:44Z","timestamp":1502324324000},"page":"547-574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Primary Cutaneous B-cell Lymphomas"],"prefix":"10.1016","volume":"37","author":[{"given":"Charity B.","family":"Hope","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura B.","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cll.2017.05.009_bib1","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2017.05.009_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1182\/blood.V99.3.800","article-title":"Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients","volume":"99","author":"Fink-Puches","year":"2002","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2017.05.009_bib3","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.cll.2017.05.009_bib4","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cll.2017.05.009_bib5","series-title":"IARC WHO classification of tumours, No 2. Fourth edition. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Vol. 2. WHO Classification of Tumours","author":"Swerdlow","year":"2008"},{"issue":"20","key":"10.1016\/j.cll.2017.05.009_bib6","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2017.05.009_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/j.semdp.2016.11.006","article-title":"Primary cutaneous B-cell lymphomas with large cell predominance-primary cutaneous follicle center lymphoma, diffuse large B-cell lymphoma, leg type and intravascular large B-cell lymphoma","volume":"34","author":"Hope","year":"2016","journal-title":"Semin Diagn Pathol"},{"issue":"1","key":"10.1016\/j.cll.2017.05.009_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.semdp.2016.11.007","article-title":"Cutaneous marginal zone lymphomas","volume":"34","author":"Swerdlow","year":"2016","journal-title":"Semin Diagn Pathol"},{"issue":"9","key":"10.1016\/j.cll.2017.05.009_bib9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for cutaneous lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.cll.2017.05.009_bib10","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/10428190802064925","volume":"49","author":"Golling","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1365-2133.2012.11122.x","article-title":"Primary cutaneous B-cell lymphoma in Nottinghamshire U.K.: prognosis of subtypes defined in the WHO-EORTC classification","volume":"167","author":"Bessell","year":"2012","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.cll.2017.05.009_bib13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1634\/theoncologist.2015-0175","article-title":"Primary cutaneous B-cell lymphoma: management and patterns of recurrence at the multimodality cutaneous lymphoma clinic of the Ohio state university","volume":"20","author":"Haverkos","year":"2015","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.cll.2017.05.009_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2559.1993.tb00469.x","article-title":"Cutaneous immunocytomas: a clinicopathologic study of 26 cases","volume":"23","author":"Rijlaarsdam","year":"1993","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.cll.2017.05.009_bib15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/00000478-199410000-00001","article-title":"Primary cutaneous immunocytoma. A B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia","volume":"18","author":"LeBoit","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.cll.2017.05.009_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000478-199501000-00002","article-title":"Cutaneous follicular lymphoid hyperplasia with monotypic plasma cells. a clinicopathologic study of 18 patients","volume":"19","author":"Schmid","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.cll.2017.05.009_bib17","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/00000478-199711000-00012","article-title":"Are primary cutaneous immunocytoma and marginal zone lymphoma the same disease?","volume":"21","author":"Duncan","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.cll.2017.05.009_bib18","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1182\/blood-2005-09-3679","article-title":"Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation","volume":"107","author":"Suarez","year":"2006","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11864-015-0344-6","article-title":"The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomas","volume":"16","author":"Foster","year":"2015","journal-title":"Curr Treat Options Oncol"},{"issue":"8","key":"10.1016\/j.cll.2017.05.009_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1600-0560.1997.tb01318.x","article-title":"Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma","volume":"24","author":"Cerroni","year":"1997","journal-title":"J Cutan Pathol"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00000478-200305000-00017","article-title":"Borrelia-associated primary cutaneous MALT lymphoma in a nonendemic region","volume":"27","author":"de la Fouchardiere","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.cll.2017.05.009_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/00000478-200009000-00012","article-title":"Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the highlands of Scotland","volume":"24","author":"Goodlad","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.cll.2017.05.009_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/cncr.27773","article-title":"Survival of patients with marginal zone lymphoma: analysis of the surveillance, epidemiology, and end results database","volume":"119","author":"Olszewski","year":"2013","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.cll.2017.05.009_bib24","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.cll.2017.05.009_bib25","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib26","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00000478-200304000-00014","article-title":"Marginal zone B-cell lymphoma in children and young adults","volume":"27","author":"Taddesse-Heath","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib27","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/bjd.14932","article-title":"Paediatric primary cutaneous marginal zone B-cell lymphoma: does it differ from the adult counterpart?","volume":"176","author":"Amitay-Laish","year":"2016","journal-title":"Br J Dermal"},{"issue":"9","key":"10.1016\/j.cll.2017.05.009_bib28","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/jdv.13044","article-title":"Paediatric cutaneous lymphomas: a review and comparison with adult counterparts","volume":"29","author":"Kempf","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.0736-8046.2004.21500.x","article-title":"The spectrum of cutaneous lymphomas in patients less than 20 years of age","volume":"21","author":"Fink-Puches","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.cll.2017.05.009_bib30","series-title":"Skin lymphoma","first-page":"201","article-title":"Cutaneous marginal zone lymphoma (cutaneous MALT lymphoma) and variants","author":"Cerroni","year":"2014"},{"issue":"11","key":"10.1016\/j.cll.2017.05.009_bib31","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/00000478-199711000-00005","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma","volume":"21","author":"Cerroni","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.cll.2017.05.009_bib32","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archderm.141.9.1139","article-title":"Primary cutaneous marginal zone B-cell lymphoma: clinical and therapeutic features in 50 cases","volume":"141","author":"Hoefnagel","year":"2005","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.cll.2017.05.009_bib33","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1080\/10428190701618250","article-title":"Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association","volume":"48","author":"Goteri","year":"2007","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.cll.2017.05.009_bib34","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1634\/theoncologist.2011-0108","article-title":"Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas","volume":"16","author":"Ponzoni","year":"2011","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.cll.2017.05.009_bib35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1034\/j.1600-0560.2001.281002.x","article-title":"Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States","volume":"28","author":"Wood","year":"2001","journal-title":"J Cutan Pathol"},{"issue":"12","key":"10.1016\/j.cll.2017.05.009_bib36","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1038\/modpathol.2008.159","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a molecular and linicopathological study of cases from Asia, Germany, and the United States","volume":"21","author":"Takino","year":"2008","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.cll.2017.05.009_bib37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00000478-200308000-00003","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases","volume":"27","author":"Li","year":"2003","journal-title":"Am J Surg Patrol"},{"issue":"3","key":"10.1016\/j.cll.2017.05.009_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.06.011","article-title":"Primary cutaneous B-cell lymphomas: part II. Therapy and future directions","volume":"69","author":"Su\u00e1rez","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib39","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2017.05.009_bib40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2013.04.047","article-title":"Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients","volume":"69","author":"Servitje","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.cll.2017.05.009_bib41","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00000478-199608000-00010","article-title":"Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients","volume":"20","author":"Bailey","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib42","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archderm.139.4.475","article-title":"Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases","volume":"139","author":"Requena","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.cll.2017.05.009_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jaad.2009.07.047","article-title":"Cutaneous involvement with marginal zone lymphoma","volume":"63","author":"Gerami","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.cll.2017.05.009_bib44","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2141.2008.07159.x","article-title":"Results of bone marrow examination in 275 patients with histological features that suggest an indolent type of cutaneous B-cell lymphoma","volume":"142","author":"Senff","year":"2008","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.cll.2017.05.009_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/DAD.0000000000000401","article-title":"Epidermotropic B-cell lymphoma: a unique subset of CXCR3-positive marginal zone lymphoma","volume":"38","author":"Magro","year":"2016","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/cup.12114","article-title":"Epidermotropic marginal zone lymphoma simulating mycosis fungoides","volume":"40","author":"Lee","year":"2013","journal-title":"J Cutan Pathol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib47","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1046\/j.1365-2133.2002.04961.x","article-title":"Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases","volume":"147","author":"Servitje","year":"2002","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.cll.2017.05.009_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/DAD.0b013e318267495f","article-title":"Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature","volume":"35","author":"Magro","year":"2013","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib49","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000478-200106000-00004","article-title":"Cutaneous B-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"5 Suppl","key":"10.1016\/j.cll.2017.05.009_bib50","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.jaad.2008.04.029","article-title":"Persistent CD20-negative primary cutaneous marginal zone lymphoma after treatment with intralesional rituximab therapy","volume":"59","author":"Lozzi","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.cll.2017.05.009_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/DAD.0b013e31804795a6","article-title":"Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH\/BCL2 and the t(14;18)(q32;q21) IGH\/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?","volume":"29","author":"Palmedo","year":"2007","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.cll.2017.05.009_bib53","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib54","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaad.2010.10.036","article-title":"Acneiform presentation of primary cutaneous follicle center lymphoma","volume":"65","author":"Soon","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cll.2017.05.009_bib55","series-title":"Skin lymphoma","first-page":"185","article-title":"Cutaneous follicular center lymphoma","author":"Cerroni","year":"2014"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib56","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2010.06.059","article-title":"Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment","volume":"65","author":"Gulia","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib57","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jaad.2008.08.005","article-title":"Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab","volume":"59","author":"Morales","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.cll.2017.05.009_bib58","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.cll.2017.05.009_bib59","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.cll.2017.05.009_bib60","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":"Primary cutaneous follicle center cell lymphoma with follicular growth pattern","volume":"95","author":"Cerroni","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2017.05.009_bib61","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00000372-200402000-00002","article-title":"Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern","volume":"26","author":"Leinweber","year":"2004","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib62","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00000372-200008000-00001","article-title":"Cutaneous spindle-cell B-cell lymphoma: a morphologic variant of cutaneous large B-cell lymphoma","volume":"22","author":"Cerroni","year":"2000","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib63","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PAS.0000000000000388","article-title":"Cutaneous spindle-cell B-cell lymphomas:most are neoplasms of follicular center cell origin","volume":"39","author":"Charli-Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.cll.2017.05.009_bib64","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":"IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib65","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jaad.2006.12.026","article-title":"New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas","volume":"56","author":"Hallermann","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.cll.2017.05.009_bib66","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2003-08-2726","article-title":"Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas","volume":"103","author":"Grange","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.cll.2017.05.009_bib67","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.cll.2017.05.009_bib68","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.leukres.2011.06.004","article-title":"The expression of IgM is helpful in the differentiation of primary cutaneous diffuse large B cell lymphoma and follicle center lymphoma","volume":"35","author":"Demirkesen","year":"2011","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.cll.2017.05.009_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/his.12855","article-title":"Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of theTAp63 isoform","volume":"69","author":"Robson","year":"2016","journal-title":"Histopathology"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib70","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/DAD.0b013e31818118f7","article-title":"Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates","volume":"30","author":"Morales","year":"2008","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"10.1016\/j.cll.2017.05.009_bib71","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/DAD.0000000000000022","article-title":"Clonality assessment of cutaneous B-cell lymphoid proliferations: a comparison of flow cytometry immunophenotyping, molecular studies, and immunohistochemistry\/in situ hybridization and review of the literature","volume":"36","author":"Schafernak","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"10.1016\/j.cll.2017.05.009_bib72","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Pham-Ledard","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib73","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2014.01.862","article-title":"Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis","volume":"70","author":"Abdul-Wahab","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib74","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00000478-200604000-00015","article-title":"Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas","volume":"30","author":"Streubel","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib75","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ajh.20572","article-title":"Primary cutaneous follicle center lymphoma of the arm with a novel chromosomal translocation t(12;21)(q13;q22): a case report","volume":"81","author":"Jelic","year":"2006","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib76","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/AJCPV3F9BEFCTAOQ","article-title":"Primary cutaneous follicle center lymphoma associated with an extracutaneous dissemination: a cytogenetic finding of potential prognostic value","volume":"144","author":"Subramaniyam","year":"2015","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib77","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","article-title":"Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France","volume":"150","author":"Grange","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.cll.2017.05.009_bib78","series-title":"Skin lymphoma","first-page":"220","article-title":"Cutaneous diffuse large B-cell lymphoma, leg type","author":"Cerroni","year":"2014"},{"issue":"7","key":"10.1016\/j.cll.2017.05.009_bib79","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/DAD.0b013e3181eeb433","article-title":"The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases","volume":"33","author":"Plaza","year":"2011","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.cll.2017.05.009_bib80","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.jaad.2015.02.1134","article-title":"Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"72","author":"Massone","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.cll.2017.05.009_bib81","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 somatic mutation is a diagnostic criterion in primary cutaneous large B-cell lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"11","key":"10.1016\/j.cll.2017.05.009_bib82","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","article-title":"High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type","volume":"150","author":"Pham-Ledard","year":"2014","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib83","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/jid.2008.357","article-title":"Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"129","author":"Senff","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.cll.2017.05.009_bib84","first-page":"826","article-title":"An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome","volume":"111","author":"Murase","year":"2000","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.cll.2017.05.009_bib85","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3324\/haematol.10829","article-title":"Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions","volume":"92","author":"Ferreri","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.cll.2017.05.009_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the cutaneous variant","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cll.2017.05.009_bib87","series-title":"Skin lymphoma","first-page":"232","article-title":"Intravascular large cell lymphomas","author":"Cerroni","year":"2014"},{"issue":"2","key":"10.1016\/j.cll.2017.05.009_bib88","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1182\/blood-2006-01-021253","article-title":"Intravascular large B-cell lymphoma (IVLBCL): a clinicopathologic study of 96 cases with special reference to the immunophenotypic heterogeneity of CD5","volume":"109","author":"Murase","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2017.05.009_bib89","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2141.2010.08354.x","article-title":"Molecular analysis of intravascular large B-cell lymphoma with neoangiogenesis","volume":"152","author":"Saurel","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cll.2017.05.009_bib90","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0046-8177(00)80223-3","article-title":"Lack of CD29 (beta1 integrin) and CD54 (ICAM-1) adhesion molecules in intravascular lymphomatosis","volume":"31","author":"Ponzoni","year":"2000","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.cll.2017.05.009_bib91","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10014-008-0232-x","article-title":"Immunohistochemical analysis of adhesion molecules and matrix metalloproteinases in malignant CNS lymphomas:a study comparing primary CNS malignant and CNS intravascular lymphomas","volume":"25","author":"Kinoshita","year":"2008","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"10.1016\/j.cll.2017.05.009_bib92","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jaad.2009.02.007","article-title":"Analysis of CXCL9 and CXCR3 expression in a case of intravascular large B-cell lymphoma","volume":"61","author":"Kato","year":"2009","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271217300458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271217300458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T19:08:58Z","timestamp":1602702538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271217300458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0272271217300458"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2017.05.009","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Cutaneous B-cell Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2017.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}